Yersinia Diagnostics Market - Forecast(2024 - 2030)

Report Code: HCR 77732 Report Format: PDF + Excel

Yersinia Diagnostics Market Overview

Yersinia Diagnostics Market size was estimated at $246.8 billion in 2020, estimated to grow at a CAGR of 6.7% during the forecast period 2021-2026. Yersinia is rod-shaped, gram-negative bacteria that belongs to the Enterobacteriaceae family. The species of Yersinia include Yersinia enteroclitica, Yersinia pseudotuberculosis, and Yersinia pestis. Bubonic plague is caused by Yersinia pestis, which is spread by infective fleas and rodents. Infectious flea to human, mouse to human, and human to human transmission are some of the modes of transmission for these bacteria. 
Gastroenteritis is caused by Yersinia pseudotuberculosis and Yersinia enterocolitica. They are foodborne bacteria and cause diseases like diarrhea, gastroenteritis, and vomiting. Sometimes by the nature of Yersiniosis (a disease caused by Yersinia pseudotuberculosis and Yersinia enterocolitica), it is often mistaken to diagnose as Appendicitis and Crohn’s disease. It is found in animals such as birds, pigs, beavers, dogs, cats as well as in environmental sources like water and soil. 
The growing prevalence of Bubonic plague and Yersiniosis is boosting the market for Yersinia diagnostics Market.  According to CDC, Yersiniosis generally cures on its own, however, various antibiotics and combinations of antibiotics are used to treat more severe infections. For instance, Third-generation cephalosporin, fluoroquinolones, tetracycline, Trimethoprim, and sulfamethoxazole, are commonly used in combination with some other antibiotics, where fluoroquinolones is used alone and sometimes in combination as an antibiotic treatment to Yersinia enterocolitica. 
The combination of Trimethoprim and sulfamethoxazole inhibits the growth of bacteria by inhibiting the synthesis of dihydrofolic acid. Aminoglycoside is a class of antibiotics that are active against various Gram-negative and Gram-positive bacteria. They are especially potent against the Enterobacteriaceae family. In the U.S. amikacin, gentamicin, tobramycin, plazomicin, neomycin, streptomycin, and paromomycin are the antibiotics approved by US Food and Administration (FDA).

Report Coverage

The report: “Yersinia Diagnostics Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Yersinia Diagnostics Market.
By Test: ELISA, Stool Culture, Radioimmunoassay, tube Agglutination, Ultrasonography, CT Scans, Colonoscopy
By Technology: Immunoassay, DNA Probes, Monoclonal Antibodies, PCR, Flow Cytometry, Chromatography
By End User: Hospitals, Public Health Laboratories and Private Laboratories
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East and Africa)

Key Takeaways                                                                                            

  • Geographically, North America Yersinia Diagnostics Market held the largest revenue share of 43% in 2020 owing to the rising number of cases suffering from bubonic plague in this region.
  • Increase in demand for R&D made by the key players in different regions coupled with growing FDA approvals for Yersinia Diagnostics is boosting the market growth.
  • Globally increase in the prevalence of Yersiniosis and Bubonic plague are the other factors boosting the market growth and provide lucrative growth opportunities for global market expansion.

Yersinia Diagnostics Market: Market Share (%) by Region, 2020


For more details on this report - Request for Sample

Yersinia Diagnostics Market Segment Analysis – By Technology:

Based on Technology, Yersinia Diagnostics Market is segmented into ELISA, Stool Culture, Radioimmunoassay, tube Agglutination, Ultrasonography, CT Scans, Colonoscopy. Stool Culture is accounted for the largest revenue market share in 2020 owing to its features such as rapid diagnosis with better efficiency. Yersiniosis is often diagnosed by detecting the pathogen in the stool of the infected person. In this, the monoclonal antibodies are directed against Yersinia enterocolitica and Yersinia pseudotuberculosis biosteriotypes. 
After testing for specificity and affinity for enteropathogenic, pairs of monoclonal antibiotics are selected to develop highly sensitive enzyme immunoassay and lateral flow immunoassays for rapid diagnosis. Yersinia pestis is detected from blood cultures by flow cytometry technology for rapid antibiotic susceptibility. 
ELISA is anticipated to grow with the fastest CAGR of 7.3% in the forecast period 2021-2026 owing to its rapid and accurate results, high sensitivity and ease to perform. ELISA tests are qualitative and quantitative immunoassays used to detect human antibodies in the serum or plasma that is directed against plasmid-encoded virulence markers of Yersinia. It is recommended for the differentiation of acute and recent infections during the case of gastrointestinal diseases.

Yersinia Diagnostics Market Segment Analysis – By End User:

Hospitals segment accounted for the largest revenue market share in 2020 owing to the huge number of patient’s footfall in addition to availability of developed and latest infrastructure and rising investments to develop infrastructure, skilled professionals, and easy accessibility.
According to National Health Expenditure, around 32% accounts to hospital care out of the total healthcare expenditure. Private Laboratories is predicted to grow with the fastest CAGR of 7.5% in the forecast period 2021-2026 owing to the growing preference towards the healthcare setting particularly in developed countries, infrastructure improvements to offer best class health facilities to the patients.

Yersinia Diagnostics Market Segment Analysis – By Geography:

Based on Geography, North America Yersinia Diagnostics Market accounted for the 43% revenue share in 2020. This is majorly attributed to the rising number of bubonic plague and the presence of local key market players in this region. According to CDC, on average 7 human plague cases are reported each year in recent decades. 
It is reported that plague has occurred to people of different ages like from infants to adults aging 96 years, where 50% of cases were noticed in people aged between 12-45 years. 
Asia-Pacific is poised to fastest CAGR in the forecast period 2021-2026 owing to its increase in the prevalence of yersiniosis, increasing health care expenditure coupled with government initiatives and other health policies in this region is contributing to the growth of the market in this region. 
Further, the presence of lucrative opportunities in emerging Asia countries coupled with the high prevalence of the disease in Japan, China are the other factors that aid the growth of the market.

Yersinia Diagnostics Market-Drivers

Growing Prevalence of Bubonic Plague and Yersiniosis:

Plague is affected to humans and other mammals. Yersinia pestis is the bacteria that causes Bubonic plague. Humans generally get it after being bitten by a rodent flea that is a carrier of plague bacterium or by simply handling an animal infected plague. In the 1970s, Yersinia pestis was first identified by Cellular fatty acid (CFA) analysis by gas chromatography. In today’s situation, modern antibiotics are seemed to be more effective in treating plague, but with lack of proper treatment, it can cause serious illness or even death. 
According to CDC, currently, human plague infections are still continuing to occur in rural areas in the Western United States, but it significantly occurs more in parts of Africa and Asia. Furthermore, annually in United States Yersiniosis is reported to cause approximately 117,000 illness, 640 hospitalizations, and over 35 deaths. Children are reported to be infected more often than adults and is likely to drive the market growth.

Yersinia Diagnostics Market-Challenges:

Difficulties in Isolation:

Enteropathogenic Yersinia species are rarely investigated in clinical laboratories owing to their unique growth characteristics that makes it difficult to isolate them from the stool samples. Furthermore, the current isolation procedures are often time-consuming and are expensive, thereby leading to underestimates of the incidences of the enteric Yersiniosis and hampering the market growth.

Yersinia Diagnostics Market Segment Landscape:

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Yersinia Diagnostics Market. Yersinia Diagnostics Market top 10 companies are F. Hoffmann La-Roche, Abbott Laboratories, Affymetrix, Becton Dickinson, Hologic, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories.

Acquisitions/Product Launches:

  • In the Year 2019, Danaher has announced to enter an agreement with General Electricity Company to acquire the Biopharma business of GE Life Sciences for a cash purchase of around $21.4 billion.

Related Reports:

Report Code: HCR 77732

Report Code: HCR 0068

For more Lifesciences and Healthcare related reports, please click here
1. Yersinia Diagnostics Market - Overview
    1.1 Definitions and Scope
2. Yersinia Diagnostics Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Type
    2.3 Key trends by Technology
    2.4 Key trends by End User
    2.5 Key trends by Geography
3. Yersinia Diagnostics Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split - Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis – Average Selling Price
4. Yersinia Diagnostics Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Yersinia Diagnostics Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Yersinia Diagnostics Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Yersinia Diagnostics Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Yersinia Diagnostics Market – By Type (Market Size –$Million/$Billion)
    8.1 ELISA
    8.2 Stool culture
    8.3 Radioimmunoassay
    8.4 Tube Agglutination 
    8.5 Ultrasonography
    8.6 CT Scan
    8.7 Colonoscopy
9. Yersinia Diagnostics Market – By Technology (Market Size –$Million/$Billion)
    9.1 Immunoassay
    9.2 DNA Probes
    9.3 Monoclonal Antibodies
    9.4 PCR
    9.5 Flow Cytometry
    9.6 Chromatography
10. Yersinia Diagnostics Market – By End User(Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Private Laboratories
    10.3 Public Healthcare Laboratories
11. Yersinia Diagnostics Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4  South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Yersinia Diagnostics Market - Entropy
13. Yersinia Diagnostics Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Yersinia Diagnostics Market – Key Company List by Country Premium Premium
15. Yersinia Diagnostics Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10  Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Yersinia Diagnostics Product Outlook Market 2023-2030 ($M)
1.1 Molecular Diagnostics Market 2023-2030 ($M) - Global Industry Research
1.2 Gel Microdroplets Market 2023-2030 ($M) - Global Industry Research
1.3 Liposomes Market 2023-2030 ($M) - Global Industry Research
1.4 Monoclonal Antibodies Market 2023-2030 ($M) - Global Industry Research
1.5 Healthcare Information Technology Market 2023-2030 ($M) - Global Industry Research
1.6 Flow Cytometry Market 2023-2030 ($M) - Global Industry Research
1.7 Chromatography Market 2023-2030 ($M) - Global Industry Research
1.8 Artificial Intelligence Market 2023-2030 ($M) - Global Industry Research
1.9 Immunoassays Market 2023-2030 ($M) - Global Industry Research
1.10 Differential Light Scattering Market 2023-2030 ($M) - Global Industry Research
1.11 Diagnostic Imaging Market 2023-2030 ($M) - Global Industry Research
2.Global Yersinia Diagnostics Product Outlook Market 2023-2030 (Volume/Units)
2.1 Molecular Diagnostics Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Gel Microdroplets Market 2023-2030 (Volume/Units) - Global Industry Research
2.3 Liposomes Market 2023-2030 (Volume/Units) - Global Industry Research
2.4 Monoclonal Antibodies Market 2023-2030 (Volume/Units) - Global Industry Research
2.5 Healthcare Information Technology Market 2023-2030 (Volume/Units) - Global Industry Research
2.6 Flow Cytometry Market 2023-2030 (Volume/Units) - Global Industry Research
2.7 Chromatography Market 2023-2030 (Volume/Units) - Global Industry Research
2.8 Artificial Intelligence Market 2023-2030 (Volume/Units) - Global Industry Research
2.9 Immunoassays Market 2023-2030 (Volume/Units) - Global Industry Research
2.10 Differential Light Scattering Market 2023-2030 (Volume/Units) - Global Industry Research
2.11 Diagnostic Imaging Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Yersinia Diagnostics Product Outlook Market 2023-2030 ($M)
3.1 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
3.2 Gel Microdroplets Market 2023-2030 ($M) - Regional Industry Research
3.3 Liposomes Market 2023-2030 ($M) - Regional Industry Research
3.4 Monoclonal Antibodies Market 2023-2030 ($M) - Regional Industry Research
3.5 Healthcare Information Technology Market 2023-2030 ($M) - Regional Industry Research
3.6 Flow Cytometry Market 2023-2030 ($M) - Regional Industry Research
3.7 Chromatography Market 2023-2030 ($M) - Regional Industry Research
3.8 Artificial Intelligence Market 2023-2030 ($M) - Regional Industry Research
3.9 Immunoassays Market 2023-2030 ($M) - Regional Industry Research
3.10 Differential Light Scattering Market 2023-2030 ($M) - Regional Industry Research
3.11 Diagnostic Imaging Market 2023-2030 ($M) - Regional Industry Research
4.South America Yersinia Diagnostics Product Outlook Market 2023-2030 ($M)
4.1 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
4.2 Gel Microdroplets Market 2023-2030 ($M) - Regional Industry Research
4.3 Liposomes Market 2023-2030 ($M) - Regional Industry Research
4.4 Monoclonal Antibodies Market 2023-2030 ($M) - Regional Industry Research
4.5 Healthcare Information Technology Market 2023-2030 ($M) - Regional Industry Research
4.6 Flow Cytometry Market 2023-2030 ($M) - Regional Industry Research
4.7 Chromatography Market 2023-2030 ($M) - Regional Industry Research
4.8 Artificial Intelligence Market 2023-2030 ($M) - Regional Industry Research
4.9 Immunoassays Market 2023-2030 ($M) - Regional Industry Research
4.10 Differential Light Scattering Market 2023-2030 ($M) - Regional Industry Research
4.11 Diagnostic Imaging Market 2023-2030 ($M) - Regional Industry Research
5.Europe Yersinia Diagnostics Product Outlook Market 2023-2030 ($M)
5.1 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
5.2 Gel Microdroplets Market 2023-2030 ($M) - Regional Industry Research
5.3 Liposomes Market 2023-2030 ($M) - Regional Industry Research
5.4 Monoclonal Antibodies Market 2023-2030 ($M) - Regional Industry Research
5.5 Healthcare Information Technology Market 2023-2030 ($M) - Regional Industry Research
5.6 Flow Cytometry Market 2023-2030 ($M) - Regional Industry Research
5.7 Chromatography Market 2023-2030 ($M) - Regional Industry Research
5.8 Artificial Intelligence Market 2023-2030 ($M) - Regional Industry Research
5.9 Immunoassays Market 2023-2030 ($M) - Regional Industry Research
5.10 Differential Light Scattering Market 2023-2030 ($M) - Regional Industry Research
5.11 Diagnostic Imaging Market 2023-2030 ($M) - Regional Industry Research
6.APAC Yersinia Diagnostics Product Outlook Market 2023-2030 ($M)
6.1 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
6.2 Gel Microdroplets Market 2023-2030 ($M) - Regional Industry Research
6.3 Liposomes Market 2023-2030 ($M) - Regional Industry Research
6.4 Monoclonal Antibodies Market 2023-2030 ($M) - Regional Industry Research
6.5 Healthcare Information Technology Market 2023-2030 ($M) - Regional Industry Research
6.6 Flow Cytometry Market 2023-2030 ($M) - Regional Industry Research
6.7 Chromatography Market 2023-2030 ($M) - Regional Industry Research
6.8 Artificial Intelligence Market 2023-2030 ($M) - Regional Industry Research
6.9 Immunoassays Market 2023-2030 ($M) - Regional Industry Research
6.10 Differential Light Scattering Market 2023-2030 ($M) - Regional Industry Research
6.11 Diagnostic Imaging Market 2023-2030 ($M) - Regional Industry Research
7.MENA Yersinia Diagnostics Product Outlook Market 2023-2030 ($M)
7.1 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
7.2 Gel Microdroplets Market 2023-2030 ($M) - Regional Industry Research
7.3 Liposomes Market 2023-2030 ($M) - Regional Industry Research
7.4 Monoclonal Antibodies Market 2023-2030 ($M) - Regional Industry Research
7.5 Healthcare Information Technology Market 2023-2030 ($M) - Regional Industry Research
7.6 Flow Cytometry Market 2023-2030 ($M) - Regional Industry Research
7.7 Chromatography Market 2023-2030 ($M) - Regional Industry Research
7.8 Artificial Intelligence Market 2023-2030 ($M) - Regional Industry Research
7.9 Immunoassays Market 2023-2030 ($M) - Regional Industry Research
7.10 Differential Light Scattering Market 2023-2030 ($M) - Regional Industry Research
7.11 Diagnostic Imaging Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
2.Canada Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
3.Mexico Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
4.Brazil Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
5.Argentina Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
6.Peru Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
7.Colombia Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
8.Chile Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
9.Rest of South America Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
10.UK Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
11.Germany Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
12.France Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
13.Italy Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
14.Spain Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
16.China Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
17.India Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
18.Japan Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
19.South Korea Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
20.South Africa Yersinia Diagnostics Market Revenue, 2023-2030 ($M)
21.North America Yersinia Diagnostics By Application
22.South America Yersinia Diagnostics By Application
23.Europe Yersinia Diagnostics By Application
24.APAC Yersinia Diagnostics By Application
25.MENA Yersinia Diagnostics By Application